Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...
A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) validates the use of Sybil, a deep learning artificial intelligence ...
Informed and shared decision-making is essential in lung cancer treatment, emphasizing clinical trial participation for advancing therapies. CheckMate 816 study showed improved overall survival with ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
Please provide your email address to receive an email when new articles are posted on . Many patients with lung cancer and their caregivers reported they lacked involvement in decision-making. Complex ...
Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of ...
(Barcelona, Spain September 9, 2025, 10:15 a.m. CEST / UTC +2) — A large-scale survey conducted by Lung Cancer Europe (LuCE) has identified critical communication barriers that affect information ...
We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback